IPI vs NTR: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
NTR is the larger of the two ($30.92B market cap): the incumbent the market prices for continued execution (12.76x forward earnings, beta 1.13). IPI is the smaller challenger ($397.13M), actually pricier on forward earnings (30.65x): more room to run, but more to prove. If you believe in growth, IPI fits: analysts expect its revenue to rise 4% next year, against a 1% decline for NTR. If you believe in paying less for profit, NTR fits: it trades at 12.76x forward earnings, against 30.65x for IPI.
IPI vs NTR: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | IPI | NTR | What it tells you |
|---|---|---|---|
| Market cap | $397.13M | $30.92B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 30.65 | 12.76 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 37.14 | 14.24 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 1.04 | 1.13 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 21% of range | 33% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 0.76 | 1.20 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: NTR is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how IPI and NTR affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. IPI and NTR share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined IPI and NTR exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Intrepid Potash (IPI) do?
Intrepid Potash, Inc. mines and sells potassium-based fertilizers from a handful of US sites. It is the only domestic producer of muriate of potash (MOP), the standard potassium fertilizer, which it makes by solar evaporation at its HB and Moab solution mines and at Wendover, Utah, plus conventional mining near Carlsbad, New Mexico. Its East mine in Carlsbad also produces langbeinite, a sulfate of potash magnesia sold under the Trio brand, which carries potassium, magnesium and sulfur in one granule and is used on chloride-sensitive crops and pasture. Intrepid also earns smaller sums from water sales, salt and magnesium chloride byproducts. In April 2026 it closed the sale of most of its Intrepid South oilfield water and land assets for a final ~$68.9 million, and that business is now reported as discontinued.
What does Nutrien (NTR) do?
Nutrien is a Canadian-headquartered agricultural giant formed from the 2018 merger of Potash Corp and Agrium, and it reports in U.S. dollars. The company runs four segments: Retail (Nutrien Ag Solutions), which distributes crop nutrients, crop protection, seed and services to farmers through a large network of stores across North America, South America and Australia, plus three upstream segments (Potash, Nitrogen and Phosphate) that mine and manufacture the fertilizers themselves. Nutrien is the largest potash producer in the world by capacity and one of the largest nitrogen producers, so its upstream results move directly with global fertilizer benchmarks, while Retail earns more stable margins from proprietary products and services.
IPI vs NTR: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.
- IPI drivers: Trio volumes and pricing; Potash cost per ton.
- NTR drivers: Potash pricing and record volumes; Nitrogen leverage to natural gas.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Intrepid is small, so a single weak harvest or a price move hits results hard. For NTR, the dominant risk is commodity price cyclicality: potash, nitrogen and phosphate prices can fall sharply, and because upstream margins are highly operationally geared, consolidated earnings can drop far faster than revenue.
IPI or NTR: which should you pick?
If the story you believe is IPI's (Trio volumes and pricing), IPI is the more direct way to own it; if it is NTR's (Potash pricing and record volumes), NTR is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the IPI and NTR guides.
IPI vs NTR: the full fundamentals
IPI. At $29.78 on November 20, 2026 and ~13.2 million shares, Intrepid's market value is ~$400 million. Subtracting ~$161 million of net cash and short-term investments gives an enterprise value near ~$240 million, or about 3.7 times trailing adjusted EBITDA of ~$65 million, and the shares trade at about 0.8 times book value. GAAP earnings look much thinner: continuing-operations net income was ~$11 million over the trailing year, because depreciation on the mines is large relative to profit. Adjusted EPS over the last four quarters was ~$1.80. UBS rates the stock Sell with a ~$29 target (raised in August), while Freedom Broker, which initiated at Buy with a ~$45 target in July, trimmed it to ~$40 on November 7, for an average near ~$34.50.
NTR. As of November 20, 2026 NTR trades near $65.38 for a market cap of roughly $31 billion, at a trailing P/E around 14.3, a forward P/E near 12.8 and about 8 times EBITDA, modest multiples typical of a cyclical commodity producer. The business is seasonal, with the spring planting quarter usually the strongest (about $10.6 billion of revenue in Q2 2026 versus about $5.8 billion in each of Q1 and Q3), and analysts expect 2026 EPS near $4.72 rising to about $5.11 in 2027. Because so much of the profit is commodity-driven, valuation multiples on trailing earnings can look cheap near cycle peaks and expensive near troughs, so context on where fertilizer prices sit matters more than the headline P/E.
Headline figures (approximate, November 2026): IPI shows revenue (ttm) ~$290 million, adjusted ebitda (ttm) ~$65 million, net income, continuing ops (ttm) ~$11 million, market cap ~$400 million at $29.78 (Nov 20, 2026); NTR shows share price / market cap ~$65.38 / ~$31 billion (Nov 20, 2026), revenue (ttm) ~$27.4 billion (Q3 2026 +~1% YoY), q3 2026 revenue / net earnings ~$5.81 billion / ~$284 million, eps (q3 2026 vs estimate) ~$0.61 vs ~$0.78.
The bottom line: IPI vs NTR
IPI and NTR are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined IPI and NTR exposure against your real portfolio. It is not an investment adviser.
Wondering how IPI or NTR fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Intrepid Potash
Ask Walnut's AI anything about IPI and see how it fits what you own.
FAQ
What is the difference between IPI and NTR?
+
Intrepid Potash, Inc. Nutrien is a Canadian-headquartered agricultural giant formed from the 2018 merger of Potash Corp and Agrium, and it reports in U.S. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is IPI or NTR the better stock?
+
Neither is universally better. NTR is the larger incumbent; IPI is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, IPI or NTR?
+
On forward P/E (as of November 2026), IPI trades at 30.65x and NTR at 12.76x, so NTR is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both IPI and NTR?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of IPI vs NTR?
+
IPI: Intrepid is small, so a single weak harvest or a price move hits results hard. Potash prices are set globally by much larger producers in Canada, Russia and Belarus, and Intrepid's realized price of ~$394 per ton in Q3 sat only slightly above its ~$384 cost per ton, leaving little cushion if prices soften; management already expects Q4 potash pricing to be flat to slightly lower. Solar evaporation production depends on weather, evaporation rates and harvest timing, as the delayed Moab season showed. Trio demand ties to US farm economics, crop prices and dealer inventories, and the new ~$440 list price could meet resistance. Growth plans rely on mine development and an SOP facility whose federal funding is proposed, not final, and whose investment decision is a year or more away. The lithium study has slipped. Water sales are lumpy and fell year over year for the nine months. Analyst coverage is thin, with two covering analysts at opposite ratings (UBS at Sell with a ~$29 target, Freedom Broker at Buy with ~$40 as of November 2026), and trading volume in a ~13.2 million share company can be light, which can widen price swings. The share price has been volatile: IPI is down about 21% over three months even after the Q3 beat, within a 52-week range of roughly $24 to $50. NTR: The dominant risk is commodity price cyclicality: potash, nitrogen and phosphate prices can fall sharply, and because upstream margins are highly operationally geared, consolidated earnings can drop far faster than revenue. Natural gas cost spikes would squeeze nitrogen margins, and weather, crop prices and farmer income drive demand for both fertilizer and Retail products in ways Nutrien cannot control. Geopolitics matters heavily, since sanctions, tariffs and shifts in Russian and Belarusian potash supply move global benchmarks. Foreign-exchange swings (the company operates globally but reports in USD) and heavy capital spending on mines and plants add further variability. Finally, the fertilizer industry is concentrated and has faced antitrust and price-fixing litigation, an overhang for the whole peer group. Two nearer-term points stand out as of November 2026. Nutrien has missed consensus EPS in each of the last four reported quarters, and the third-quarter 2026 miss was the largest ($0.61 against about $0.78), with trailing earnings down about 38% year over year in the latest quarter; UBS rates the shares a sell with a $63 target. The balance sheet also carries about $14.1 billion of debt against under $1 billion of cash, up from about $12.7 billion earlier in the year, manageable at today's cash flows (about $4.2 billion of trailing operating cash flow) but a constraint if a fertilizer downturn arrives.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell IPI or NTR; figures are approximate and dated (as of November 2026). Verify current data before investing.